BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...

While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most ...

Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment. In an update on ClinicalTrials.gov, the company stated the study (NCT05626322) was ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...

This was the stock's third consecutive day of losses.

Pfizer CEO Albert Bourla heralded the site launch in a post on LinkedIn, noting that PfizerForAll seeks to aid Americans “overwhelmed by the abundance of online health information.” Going forward, the ...

This was the stock's second consecutive day of losses.